Pekka Lähteenmäki

article 2003

Subdermal progestin implant (Nestorone ® ) in the treatment of endometriosis: clinical response to various doses

·doi:10.1080/j.1600-0412.2003.00054.x

ObjectiveTo evaluate the efficacy of three different doses of Nestorone progestin administered by implants for relief of pain, as well as bleeding patterns and symptoms in women with endometriosis.DesignAn open clinical study without a cont…

article 2003

Subdermal progestin implant (Nestorone®) in the treatment of endometriosis: clinical response to various doses

Acta obstetricia et gynecologica Scandinavica ·doi:10.1034/j.1600-0412.2003.00054.x

OBJECTIVE: To evaluate the efficacy of three different doses of Nestorone progestin administered by implants for relief of pain, as well as bleeding patterns and symptoms in women with endometriosis. DESIGN: An open clinical study without a…

article 1996

Pharmacokinetics of mifepristone after low oral doses

·doi:10.1016/s0010-7824(96)00193-x

Relatively low doses of the antiprogestin mifepristone (RU 486) have recently proven to be efficient for a variety of possible clinical uses of the drug. However, the pharmacokinetics after low single oral doses have not been characterized.…

article 1993

Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception

·doi:10.1016/s0015-0282(16)56209-8

ObjectiveTo examine the effect of sequential use of the antiprogesterone RU486 and synthetic progestin on ovarian function of healthy women.DesignHealthy women were given a sequential antiprogesterone-progestin treatment. Blood samples were…